Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,307.20 -80.41 -0.52%
S&P 500 1,655.35 -13.81 -0.83%
Nasdaq 3,463.30 -38.82 -1.11%
Ticker Volume Price Price Delta
STOXX 50 2,835.01 +13.36 0.47%
FTSE 100 6,840.27 +36.40 0.53%
DAX 8,530.89 +58.69 0.69%
Ticker Volume Price Price Delta
Nikkei 15,663.00 +35.69 0.23%
Hang Seng 22,878.20 -382.86 -1.65%
S&P/ASX 200 5,076.00 -89.37 -1.73%
  • Exchange: NASDAQ CM
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

StemCells Inc

+ Add to Watchlist

STEM:US

1.8700 USD 0.0100 0.54%

As of 20:10:00 ET on 05/22/2013.

Company Profile for StemCells Inc (STEM)

StemCells, Inc. is a biotechnology company. The Company discovers, develops, and commercializes stem cell-based therapies to treat diseases of the central nervous system, liver, and the pancreas. StemCells seeks to repair or repopulate neural, or other tissue that has been damaged or lost as a result of disease of injury.

Contact Information

StemCells Inc

3155 Porter Drive
Palo Alto, CA 94304
United States
Phone: 1-650-475-3100
Fax: 1-650-475-3101

Key Executives for StemCells Inc (STEM)

Martin M McGlynnPresident/CEOAnn TsukamotoExec VP:Research & Devpt
Stewart CraigSenior VP:Devpt & OperationsK B Young "Rodney"VP:Finance & Admin/CFO
Kenneth B StrattonSecretary/General Counsel

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil